Scott A. Soefje, PharmD, MBA, BCOP, FCCP, FHOPA

Oncology Pharmacists Connect 2026 emphasized the pharmacist’s role in translating rapidly evolving evidence into patient-centered, operationally feasible cancer care.

FDA accelerated approval speeds access but faces challenges with trial completion, costs, and end point validation.

Scott A. Soefje, PharmD, MBA, BCOP, FCCP, FHOPA, discusses how Medicaid payment changes could impact rural hospitals and local pharmacies, noting the importance of pharmacists staying involved as the situation develops.

Scott Soefje, PharmD, MBA, BCOP, shares insights about the evolving role of pharmacists at the 2025 OPC meeting.

The increasing economic burden of treatment may impact patient outcomes.